Effects of acute exercise and chronic exercise on the liver leptin-AMPK-ACC signaling pathway in rats with type 2 diabetes
- PMID: 24455748
- PMCID: PMC3877642
- DOI: 10.1155/2013/946432
Effects of acute exercise and chronic exercise on the liver leptin-AMPK-ACC signaling pathway in rats with type 2 diabetes
Abstract
Aim: To investigate the effects of acute and chronic exercise on glucose and lipid metabolism in liver of rats with type 2 diabetes caused by a high fat diet and low dose streptozotocin (STZ).
Methods: Animals were classified into control (CON), diabetes (DC), diabetic chronic exercise (DCE), and diabetic acute exercise (DAE) groups.
Results: Compared to CON, the leptin levels in serum and liver and ACC phosphorylation were significantly higher in DC, but the levels of liver leptin receptor, AMPK α 1/2, AMPK α 1, and ACC proteins expression and phosphorylation were significantly lower in DC. In addition, the levels of liver glycogen reduced significantly, and the levels of TG and FFA increased significantly in DC compared to CON. Compared to DC, the levels of liver AMPK α 1/2, AMPK α 2, AMPK α 1, and ACC phosphorylation significantly increased in DCE and DAE. However, significant increase of the level of liver leptin receptor and glycogen as well as significant decrease of the level of TG and FFA were observed only in DEC.
Conclusion: Our study demonstrated that both acute and chronic exercise indirectly activated the leptin-AMPK-ACC signaling pathway and increased insulin sensitivity in the liver of type 2 diabetic rats. However, only chronic and long-term exercise improved glucose and lipid metabolism of the liver.
Figures


Similar articles
-
Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes.PLoS One. 2012;7(12):e51709. doi: 10.1371/journal.pone.0051709. Epub 2012 Dec 13. PLoS One. 2012. PMID: 23272147 Free PMC article.
-
[Effects of acute and chronic exercise on fat PI3K/AKT/GLUT4 signal pathway in type 2 diabetic rats].Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2020 Jan 28;36(1):12-16. doi: 10.12047/j.cjap.5802.2020.003. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2020. PMID: 32476367 Chinese.
-
Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK.Acta Pharmacol Sin. 2009 Dec;30(12):1607-15. doi: 10.1038/aps.2009.168. Acta Pharmacol Sin. 2009. PMID: 19960007 Free PMC article.
-
Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway.Lipids Health Dis. 2024 Jan 25;23(1):28. doi: 10.1186/s12944-024-02014-2. Lipids Health Dis. 2024. PMID: 38273354 Free PMC article.
-
AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise.Acta Physiol Scand. 2003 Aug;178(4):435-42. doi: 10.1046/j.1365-201X.2003.01164.x. Acta Physiol Scand. 2003. PMID: 12864749 Review.
Cited by
-
Protective Effects of Reduced Beta 2 Glycoprotein I on Liver Injury in Streptozotocin (STZ)-Diabetic Rats by Activation of AMP-Activated Protein Kinase.Med Sci Monit. 2018 Oct 24;24:7577-7584. doi: 10.12659/MSM.909598. Med Sci Monit. 2018. PMID: 30352988 Free PMC article.
-
Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments.J Diabetes Res. 2015;2015:752481. doi: 10.1155/2015/752481. Epub 2015 Feb 9. J Diabetes Res. 2015. PMID: 25759824 Free PMC article.
-
Adenosine monophosphate-activated protein kinase activation mediates the leptin-induced attenuation of cognitive impairment in a streptozotocin-induced rat model.Exp Ther Med. 2015 May;9(5):1998-2002. doi: 10.3892/etm.2015.2317. Epub 2015 Feb 25. Exp Ther Med. 2015. PMID: 26136928 Free PMC article.
-
Targeting AMPK for cancer prevention and treatment.Oncotarget. 2015 Apr 10;6(10):7365-78. doi: 10.18632/oncotarget.3629. Oncotarget. 2015. PMID: 25812084 Free PMC article. Review.
-
Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia.PLoS One. 2017 Mar 9;12(3):e0173310. doi: 10.1371/journal.pone.0173310. eCollection 2017. PLoS One. 2017. PMID: 28278265 Free PMC article.
References
-
- Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. The New England Journal of Medicine. 2002;346(8):570–578. - PubMed
-
- Friedman JM. Modern science versus the stigma of obesity. Nature Medicine. 2004;10(6):563–569. - PubMed
-
- Mapfei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995;1(11):1155–1161. - PubMed
-
- Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. Journal of Clinical Endocrinology and Metabolism. 1997;82(2):654–657. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous